Teleflex TFX continues to report an improvement in revenues banking on balanced growth across all segments and geographies. Yet, escalating operating expenses are putting immense pressure on the ...
Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results